Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals, Inc. (ARMP) Gains from Investment Securities (2016 - 2018)

Armata Pharmaceuticals' Gains from Investment Securities history spans 5 years, with the latest figure at $337000.0 for Q4 2018.

  • For Q4 2018, Gains from Investment Securities rose 1038.63% year-over-year to $337000.0; the TTM value through Dec 2018 reached $164006.0, up 454.13%, while the annual FY2024 figure was $10.8 million, 24918.6% up from the prior year.
  • Gains from Investment Securities for Q4 2018 was $337000.0 at Armata Pharmaceuticals, up from $3201.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $547181.0 in Q3 2015 and bottomed at -$362750.0 in Q2 2015.
  • The 4-year median for Gains from Investment Securities is $28697.0 (2017), against an average of $81065.1.
  • The largest annual shift saw Gains from Investment Securities plummeted 96.43% in 2017 before it surged 1038.63% in 2018.
  • A 4-year view of Gains from Investment Securities shows it stood at $547181.0 in 2015, then tumbled by 134.91% to -$190994.0 in 2016, then soared by 115.5% to $29597.0 in 2017, then soared by 1038.63% to $337000.0 in 2018.
  • Per Business Quant, the three most recent readings for ARMP's Gains from Investment Securities are $337000.0 (Q4 2018), $3201.0 (Q3 2018), and $1450.0 (Q2 2018).